KT

Katsuya Tagami

Director Director DIN 07926009
DIN 07926009 First appointment Sep 2017 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Sep 2017
Shareholding value Locked Premium profile

About Katsuya Tagami

Data last updated:

Katsuya Tagami has 9 years in corporate governance. Formerly with 1 company, such as Eisai Pharmaceuticals India Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 07926009
Primary Designation Director
First Appointment 15 Sep 2017
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Director15 Sep 20172007Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Eisai Pharmaceuticals India Private Limited
Premium access

Shareholding and investment profile for Katsuya Tagami

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Katsuya Tagami

Katsuya Tagami has 9 years in corporate governance. Formerly with 1 company, such as Eisai Pharmaceuticals India Private Limited. Engaged in General Business. Contributes to corporate operations.

Katsuya Tagami is associated with 0 companies as a director.

Katsuya Tagami has expertise in General Business.

Katsuya Tagami has 9 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available